knowledge -WSS

knowledge

author：leisure time 2025-09-09 19:33:10 - browse：21

Adobe

More than a year ago, Kaiser Permanente made waves when it said it was creating a new, sprawling entity of nonprofit hospitals and doctors with Geisinger as its first takeover — the latest example of health care companies bulking up in an already highly consolidated industry.

Nothing has happened since then, at least publicly. Geisinger’s 10 hospitals and 1,700 employed physicians are now officially part of the group, known as Risant Health. Kaiser, which is both a health insurance company and a network of providers, said it wants to add at least five to six more health systems by 2028.

Those other organizations are still a mystery. But recent financial reports show a handful of systems that have been on the same shaky trajectory as Geisinger and could find themselves in Kaiser’s crosshairs. Patients and local communities have a lot at stake if their health system gets gobbled up by Kaiser; it’s still unclear how this unique structure will alter costs or quality of care.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Walmart eyes Medicare Advantage provider ChenMed

WSS

White House touts steps to stem shortages of cancer treatments

Diverse clinical trials: Why aren’t we there yet?

FDA approves updated Covid vaccines

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Readout Newsletter: BridgeBio, Akero, and human embryo models

Lack of health data on LGBTQ+ people has serious consequences

explore

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

BioMarin wins approval for gene therapy to treat hemophilia A

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

After affirmative action ruling, medical educators look to 'holistic review'

Streamlined flu vaccines recommended by FDA advisory panel

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

A new approach to psychiatric drug development

DIEP, the 'gold standard' of breast reconstruction, is under threat

Microsoft's Peter Lee: Generative AI could help doctors be more human

What does generative AI mean for health care? We asked experts

Families look for replacement for GSK asthma drug Flovent

leisure time

Why Talkspace is targeting Medicare, a tricky market

$1 billion proposal to grow Boston, Massachusetts biotech

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

$1 billion proposal to grow Boston, Massachusetts biotech

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Walmart eyes Medicare Advantage provider ChenMed

leisure time

focus

leisure time

focus